FDA Approves Braftovi + Mektovi Combination
Array BioPharma Announces FDA Approval of Braftovi (encorafenib) in Combination with Mektovi (binimetinib) for Unresectable or Metastatic Melanoma with BRAF Mutations
BOULDER, Colo., June 27, 2018 /PRNewswire/
Health Tip: Teens E-cigarette Users More Likely to Smoke: Study
-- Students who use electronic cigarettes by the time they start ninth grade are more likely to start smoking traditional cigarettes and use other tobacco products within a year, according t
Initial Outcomes No Worse for Surgical ICU Patients With CA
FRIDAY, June 29, 2018 -- Surgical patients who are admitted to the intensive care unit (ICU) and have cancer do not have worse initial outcomes than those without cancer, according to a study pu
FDA Approves Moxidectin
FDA Approves Moxidectin for the Treatment of River Blindness
MELBOURNE, GENEVA, and NEW YORK - June 13, 2018 -- Medicines Development for Global Health (MDGH) and the World Health Organisation Special Programme for Research and T
Amblyopia, Strabismus May Slow Test Performance in Children
THURSDAY, June 14, 2018 -- Children with certain eye conditions -- amblyopia or strabismus -- require more time to fill out multiple-choice answer forms, according to a study published online Ju
When DEA Cracked Down on Opioids, Abusers Moved to Black Market: Study
FRIDAY, June 15, 2018 -- Illegal opioid sales on the internet have surged in the wake of U.S. government crackdowns on prescriptions for the highly addictive painkillers, a new study